Assembly Biosciences (ASMB) Non Operating Investment Income (2015 - 2016)
Assembly Biosciences (ASMB) posted quarterly Non Operating Investment Income of -$1.8 million for Q4 2016, down 114.41% year-over-year from $12.2 million in Q1 2016, and down 742.63% quarter-over-quarter from $273573.0 in Q3 2016.
Assembly Biosciences (ASMB) Non Operating Investment Income (2015 - 2016) Analysis & Trends
Assembly Biosciences' Non Operating Investment Income history runs 2 years deep, the most recent figure standing at -$1.8 million for Q4 2016.
- In Q4 2016, Non Operating Investment Income fell 114.41% year-over-year to -$1.8 million; the TTM figure through Dec 2016 stood at -$1.3 million (down 54.55% YoY), while the FY2017 annual figure was -$615000.0, up 46.05% from the prior year.
- Non Operating Investment Income for Q4 2016 stood at -$1.8 million, down from $273573.0 in the prior quarter.
- The five-year high for Non Operating Investment Income was $273573.0 in Q3 2016, with the low at -$1.8 million in Q4 2016.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Operating Investment Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | - |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | - |
| 10 | Assembly Biosciences | 670.88 Mn | 350.52 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2016 | -1.76 Mn |
| Dec 31, 2016 | -1.76 Mn |
| Sep 30, 2016 | 273,573.00 |
| Sep 30, 2016 | 273,573.00 |
| Jun 30, 2016 | 142,675.00 |
| Jun 30, 2016 | 142,675.00 |
| Mar 31, 2016 | 72,090.00 |
| Mar 31, 2016 | 72,090.00 |
| Dec 31, 2015 | -819,976.00 |
| Dec 31, 2015 | -819,976.00 |
| Sep 30, 2015 | -1,609.00 |
| Sep 30, 2015 | -1,609.00 |